Long Non Coding RNA in Complications of Systemic Lupus

Long Non Coding RNA IN Systemic Lupus

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03185767

Enrollment

100

Registered

2017-06-14

Start date

2016-06-01

Completion date

2017-07-01

Last updated

2017-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication in Systemic Lupus Erythematosus

Brief summary

the precise role of RNA in setting of this complication in systemic lupus erythematosus (SLE) is largely unknown

Interventions

OTHERblood sampling

blood sampling

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* with systemic lupus

Exclusion criteria

vasculitis

Design outcomes

Primary

Measure	Time frame	Description
non coding RNA expression by real time PCR	1 year	non coding RNA expression by real time PCR to evaluate thier role in lupus

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026